Patricia Ann Duffy

Array ( [id] => 4651040 [patent_doc_number] => 20080038296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'TARGETED DELIVERY OF DRUGS, THERAPEUTIC NUCLEIC ACIDS AND FUNCTIONAL NUCLEIC ACIDS TO MAMMALIAN CELLS VIA INTACT KILLED BACTERIAL CELLS' [patent_app_type] => utility [patent_app_number] => 11/765635 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26093 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038296.pdf [firstpage_image] =>[orig_patent_app_number] => 11765635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252184 [patent_doc_number] => 20100028381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'FORMULATION FOR DELIVERY OF IMMUNE RESPONSE MODIFIERS' [patent_app_type] => utility [patent_app_number] => 12/304339 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8128 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028381.pdf [firstpage_image] =>[orig_patent_app_number] => 12304339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10020650 [patent_doc_number] => 09063129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Device, kit and method for hookworm antigen capture and detection' [patent_app_type] => utility [patent_app_number] => 11/763583 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 9163 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11763583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315532 [patent_doc_number] => 20090280130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'METHOD FOR THE TREATMENT OF ANTHRAX TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/304495 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13160 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280130.pdf [firstpage_image] =>[orig_patent_app_number] => 12304495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495795 [patent_doc_number] => 20090263823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE' [patent_app_type] => utility [patent_app_number] => 12/304550 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11562 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263823.pdf [firstpage_image] =>[orig_patent_app_number] => 12304550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473058 [patent_doc_number] => 20090246224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/304320 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22290 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246224.pdf [firstpage_image] =>[orig_patent_app_number] => 12304320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4550143 [patent_doc_number] => 07960518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Human binding molecules having killing activity against enterococci and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/227116 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28789 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960518.pdf [firstpage_image] =>[orig_patent_app_number] => 12227116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915194 [patent_doc_number] => 20080095794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'RECOMBINANT BCG STRAINS WITH ENHANCED ABILITY TO ESCAPE THE ENDOSOME' [patent_app_type] => utility [patent_app_number] => 11/755936 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23566 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095794.pdf [firstpage_image] =>[orig_patent_app_number] => 11755936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 214022 [patent_doc_number] => RE040988 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-11-17 [patent_title] => 'Ligands of the neuropeptide receptor HFGAN72' [patent_app_type] => reissue [patent_app_number] => 11/807588 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 12725 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040988.pdf [firstpage_image] =>[orig_patent_app_number] => 11807588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607647 [patent_doc_number] => 08784812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Methods for treating autoimmune diseases using a TACI-Ig fusion molecule' [patent_app_type] => utility [patent_app_number] => 11/748978 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10075 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11748978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246972 [patent_doc_number] => 20070243206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'SYNTHETIC CHIMERIC FIMBRIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/745177 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243206.pdf [firstpage_image] =>[orig_patent_app_number] => 11745177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5303441 [patent_doc_number] => 20090298093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways' [patent_app_type] => utility [patent_app_number] => 12/226800 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22516 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298093.pdf [firstpage_image] =>[orig_patent_app_number] => 12226800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733382 [patent_doc_number] => 20080050361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'STAPHYLOCOCCUS AUREAS SPECIFIC ANTI-INFECTIVES' [patent_app_type] => utility [patent_app_number] => 11/740128 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050361.pdf [firstpage_image] =>[orig_patent_app_number] => 11740128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965244 [patent_doc_number] => 20080108064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'PEPTIDE NUCLEIC ACID PROBES FOR ANALYSIS OF CERTAIN STAPHLOCOCCUS SPECIES' [patent_app_type] => utility [patent_app_number] => 11/740112 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10317 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108064.pdf [firstpage_image] =>[orig_patent_app_number] => 11740112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5526809 [patent_doc_number] => 20090196886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'VACCINE AGAINST NICOTINE ADDICTION' [patent_app_type] => utility [patent_app_number] => 12/297800 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5138 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196886.pdf [firstpage_image] =>[orig_patent_app_number] => 12297800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8457581 [patent_doc_number] => 08293245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Methods and compositions based on Shiga toxin type 1 protein' [patent_app_type] => utility [patent_app_number] => 11/788546 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 9 [patent_no_of_words] => 12145 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11788546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520912 [patent_doc_number] => 20090028893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides' [patent_app_type] => utility [patent_app_number] => 11/786847 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8755 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028893.pdf [firstpage_image] =>[orig_patent_app_number] => 11786847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434996 [patent_doc_number] => 20090169582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'RECOMBINANT LACTOBACILLUS AND USE OF THE SAME' [patent_app_type] => utility [patent_app_number] => 12/297691 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27882 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169582.pdf [firstpage_image] =>[orig_patent_app_number] => 12297691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348908 [patent_doc_number] => 20100021498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'LIVE, ATTENUATED PNEUMOCOCCAL VACCINE' [patent_app_type] => utility [patent_app_number] => 12/281145 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12147 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021498.pdf [firstpage_image] =>[orig_patent_app_number] => 12281145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435165 [patent_doc_number] => 08282933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'P. gingivalis antigenic composition' [patent_app_type] => utility [patent_app_number] => 11/729218 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15520 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11729218 [rel_patent_id] =>[rel_patent_doc_number] =>)